5
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2048L | α-helical CRF 9-41 acetate | α-helical CRF 9-41 acetate(90880-23-2 Free base) | CRFR |
α-helical CRF 9-41 acetate is a competitive antagonist of CRF2 (KB = 100 nM) and a partial agonist of CRF1 (EC50 = 140 nM). | |||
TP2048 | α-Helical CRF(9-41) | α-helical CRF 9-41 | |
Corticotropin-releasing factor receptor antagonist (Ki values are 17, 5 and 0.97 at human CRF1, rat CRF2α and mouse CRF2β receptors respectively). | |||
T76204 | a-Helical Corticotropin Releasing Factor (9-41) | ||
α-Helical Corticotropin Releasing Factor (9-41) is a corticotropin releasing factor (CRF) antagonist that lowers plasma growth hormone (GH) levels in vivo [1] [2]. | |||
T75891 | α-Helical CRF(9-41) TFA | ||
α-Helical CRF(9-41) TFA acts as a competitive antagonist for the CRF2 receptor, possessing a binding constant (K B) of approximately 100 nM. Additionally, it serves as a partial agonist for the CRF1 receptor, exhibiting ... | |||
T83665 | α-Helical CRF (9-41) TFA | α-Helical Corticotropin-Releasing Factor (9-41) | |
α-Helical CRF (9-41) is a synthetic peptide antagonist that targets corticotropin-releasing factor (CRF), effectively inhibiting CRF-induced adrenocorticotropic hormone (ACTH) release both in vitro, with isolated rat ant... |